Moreover, NTRK1 expression positively correlated with KDM6A in a subset of clinical CML samples and KDM6A knockdown in fresh CML isolates decreased NTRK1 encoded protein (TRKA) expression. The gene discussed is NTRK1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.